The muscarinic antagonist
Cholinergic mechanisms occur ubiquitously in the animal kindgom (Walker et al., 1980) . Muscarinic receptors are the major type of acetylcholine (ACh) receptor in mammalian central nervous systems and may have a role in a wide variety of processes including memory storage and learning (Banks and Russell, 1967; Deutsch, 1971; Squire and Davis, 1981 ) and Alzheimer's and Huntington's diseases (Davies and Maloney, 1976; Yamamura et al., 1979) . In fact, ACh can "influence every physiological or behavioral response thus far examined" (Meyers, 1974) . Because of such general action, ACh may be necessary in the production of normal behavior but may not itself be responsible for producing any particular behavior (Russell, ' We thank Dr. Lavern Weber for making facilities available to us, and for his continuing interest and encouragement.
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1982). Thus, cholinergic mechanisms in higher animals may have such varied expression that their relationship to the principles of neuronal integration underlying behavior may be difficult to assess.
Invertebrates, insofar as they have simpler behaviors and far fewer neurons than vertebrates, offer an opportunity for studies on the relationship between transmitter systems and the integrative properties of the nervous system. For our work, we have used gastropod molluscs, sea slugs, that exhibit simple and higher order behaviors, such as associative learning, which are amenable to analysis at the cellular level (see Kandel and Schwartz, 1982, Mpitsos and Lukowiak, 1985) . However, ACh receptors in molluscs and other invertebrates have not fallen easily into Dale's nicotinic-muscarinic classification (Dale, 1914; Kehoe, 1972; Walker et al., 1980) . Previous studies of gastropods have examined choline metabolism and the physiologic responses of neurons to ACh agonists and antagonists (e.g., Deutsch, 1971; Kehoe, 1972; Eisenstadt et al., 1973; Kehoe and Marder, 1976; Treistman and Schwartz, 1977; McCaman and Ono, 1982) . These studies have demonstrated the importance of cholinergic mechanisms in molluscan nervous systems. However, the relationship of these results to mammalian muscarinic responses has been ambiguous because the physiological measurements often showed mixed nicotinic/muscarinic pharmacology. Radioligand binding techniques can characterize receptors without some of the complications of physiological assays. From such studies we report specific high affinity binding sites for a potent and specific muscarinic antagonist, L-[3H]quinuclidinyl benzilate (L-[~H] QNB) (Yamamura and Snyder, 1974) in the nervous tissue of the gastropod Aplysia californica. The pharmacology of these binding sites resembles that of mammalian muscarinic receptors. The characteristics of such Aplysia muscarinic recognition sites are consistent with studies of fruit fly, rat, dog, monkey, and human tissue (Venter et al., 1984) showing that the muscarinic cholinergic receptor site has been highly conserved through evolution. (Dowdall and Whittaker, 1973) for the head gangllon of the squid. Aplysia ganglia were homogenized in 6 to 8 vol of ice-cold 0.7 M sucrose using a Potter-Elvehjem-type Telfonglass homogenizer.
Materials and Methods
This homogenate was filtered through four layers of cheese cloth to remove any remaining connective tissue sheaths. The filtered homogenate was then centrifuged at 1,000 x g for 10 min at 4°C. The pellet (P,) was routinely discarded except in the subcellular distribution studies where it was assayed for L-[3H]QNB binding. The resulting supernatant (S,) was centrifuged at 17,500 x g for 1 hr at 4°C. This procedure resulted in a pellet (fraction P2H) and, in addition, a pellicle (fraction PZL) floating on the surface of the supernatant fluid. Due to the limited amount of nervous tissue which may be obtained from individual Aplysia, both the P2L and PZH fractions were routinely collected to maximize recovery.
The supernatant (&) was discarded.
Suspensions of osmotically disrupted synaptosomal membranes were prepared by the addition of 20 vol of ice-cold 50 mM Na-KP04 buffer (pH 7.4) to the combined PZL and P2H fractions. Thts suspension was homogenized using a Brinkman Polytron (20 set, setting no. 5) and centrifuged at 35,000 x g for 30 mln at 4°C. The resulting pellet was resuspended in 6 to 8 vol of ice-cold 50 mM Na-KP04 buffer and used Immediately in the binding assays.
Receptor binding assay. The binding of L-[3H]QNB to Aplysia membranes was determined using a previously described (Fields et al., 1978 ) rapid filtration assay with minor modifications.
Aliquots of the membrane preparation (800 ~1, 0.2 to 0.5 mg of protein) were incubated in triplicate with 100 ~1 of L-[3H]QNB and 100 ~1 of buffer or competing drugs as indicated. The reaction was initiated by the addition of tissue and incubations were routinely carried out for 2 hr at 18"C, which was the ambient temperature at which the animals had been maintained.
In preliminary studies it was determined that a 2-hr incubation time was sufficient for the specific binding of L-[~H] QNB to reach equilibrium. The specific binding was found to remain constant from 90 min to 4 hr at 18°C. Incubations were terminated by rapid filtration under vacuum through glass fiber filters (Whatman GF/C; presoaked in 0.1% poly-L-lysine solution). The filters were rapidly washed with 4 x 4 ml of icecold Na-KPO., buffer. (Fig. 1) . Moreover, when 1 PM dexetimide and 100 FM oxotremorine were co-incubated in the nonspecific binding tubes, a lack of additivity of the resulting blanks was observed (Fig.  1) . These results suggest the mutually exclusive binding of these two muscarinic ligands to a common population of binding sites labeled by L-[~H]QNB (Burt, 1978 (Table II) . Logit-log plots of the inhibition of L-[~H]QNB specific binding by the various cholinergic ligands employed are depicted in Figure 3 . The Hill coefficients 3186 Murray et al. Vol. 5, No. 12, Dec. 1985 der, 1974 (Venter, 1983; Venter et al., 1984) . Thus, the et al., 1978; Dunlap and Brown, 1983) . potential and a fast inhibitory one, appeared to be nicotinic because they were sensitive to nicotinic agents, insensitive to muscarine, and were blocked with curare. Nonetheless, hexamethonium, a ganglionic nicotinic antagonist, did not block the fast inhibitory response, and atropine, a classical muscarinic antagonist, blocked the excitatory and, occasionally, the fast inhibitory responses. Thus, these ACh-induced responses exhibited mixed nicotinic and muscarinic properties. The third response to ACh, a slow inhibitory potential, was insensitive to hexamethonium, curare, and atropine and, therefore, exhibited neither nicotinic nor muscarinic properties. Such problems of classification may arise in part from the nature of the neural tissue and from the experimental methods. Physiologic studies involve the receptor molecule, the ionophore, and other transduction components (Carpenter et al., 1977; McCaman and Ono, 1982) . Binding studies examine only the recognition component. Moreover, while physiologic studies of molluscs have required micromolar to millimolar concentrations of cholinergic agents to produce measurable responses, our binding studies were facilitated by the use of potent muscarinic antagonist ligands with nanomolar affinities for the receptor. The reason for the required high concentrations in physiologic experimentation is presently unknown, but may involve the connective tissue surrounding the nervous system, and in marine molluscs, the high salt content of the hemolymph. Nonetheless, with high concentrations the pharmacologic agents may lose their specificity by binding to other receptor populations and by affecting the ionophore (McCaman and Ono, 1982) . Thus, although we present evidence of muscarinic receptors in Aplysia and Pleurobranchaea, we are unable to assign a particular physiologic role to them based on previous physiologic studies. Although there are several known behavioral and physiological cholinergic systems in Aplysia (McCaman and Ono, 1982) , these also do not easily fit the nicotinic/muscarinic distinction, and it is presently unclear which af these involve the apparent classical muscarinic receptors that we have demonstrated. Toward the goal of establishing a behavioral assay for muscarinic action, we have preliminary evidence showing that muscarinic agents, when injected into Pleurobranchaea in concentrations that do not appear to affect normal feeding, affect the ability of animals to learn food-aversion behavior.
The demonstration of muscarinic receptors in sea slugs opens the possibility of avoiding some of the problems encountered in physiologic studies. With highly specific muscarinic agonist and antagonist ligands, it should be possible to intercede into the processes of muscarinic connections without the more promiscuous actions of ACh. Moreover, with such potent and selective pharmacologic tools and with the recent availability of purified muscarinic receptors (Peterson et al., 1984) , it may be possible to determine the locus of the muscarinic receptors in the nervous system and thereby guide neurophysiologic studies of the neuronal basis of behavior.
